Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Conversion CHAIRMAN & CEO acquired 900,000 shares (conversion)
  2. 4 Option exercise Director acquired 2,799 shares (option exercise)
  3. 4 Option exercise Director acquired 2,799 shares (option exercise)
  4. 4 Option exercise Director acquired 2,799 shares (option exercise)
  5. 4 Option exercise Director acquired 2,799 shares (option exercise)
  6. 4 Grant or award Director acquired 12,156 shares (grant or award)
  7. 4 Planned sale CHIEF MEDICAL OFFICER sold 58,424 shares at an average $53.71 ($3,137,823)
  8. 4 Planned sale CHAIRMAN & CEO sold 48,565 shares at $54.02 ($2,623,481)
  9. 4 Planned sale CHAIRMAN & CEO sold 508,339 shares at an average $51.96 ($26,415,228)
  10. 4 Planned sale Director sold 13,099 shares at $50.10 ($656,260)
  11. 4 Planned sale CHIEF ACCOUNTING OFFICER sold 6,625 shares at $46.69 ($309,321)
  12. 4 Planned sale CHIEF OPERATING OFFICER sold 1,703 shares at $46.69 ($79,513)
  13. 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 846 shares (to pay taxes)
  14. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,303 shares (to pay taxes)
  15. 4 Planned sale CHAIRMAN & CEO sold 7,278 shares at $50.01 ($363,973)
  16. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,208 shares (to pay taxes)
  17. 4 Planned sale CHIEF OPERATING OFFICER sold 2,367 shares at $48.58 ($114,989)
  18. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)
  19. 4 Planned sale Director sold 6,901 shares at $50.00 ($345,050)
  20. 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 1,756 shares (to pay taxes)

Page 2 of 20 · 385 filings